672 results match your criteria: "Lou Ruvo Center for Brain Health[Affiliation]"

Article Synopsis
  • * The event featured presentations from eight expert scientists from Europe and the U.S., drawing in over 200 attendees from various sectors, including academia, the National Institutes of Health, and the pharmaceutical industry.
  • * Discussions included techniques for identifying Lewy body and Alzheimer's pathology, as well as new potential biomarkers for these types of dementia.
View Article and Find Full Text PDF

Introduction: Outcomes after deep brain stimulation (DBS) therapy are dependent on good surgical placement in the target nucleus and optimized stimulation parameters through multiple programming sessions. This often requires frequent travel to a specialized DBS center, which presents a challenge for those with limited access. Recently, the FDA approved a remote tele-programming solution for DBS.

View Article and Find Full Text PDF

Objective: A subset of individuals with coronavirus disease 2019 (COVID-19) appears to develop persisting cognitive and medical symptoms. Research in the acute stages of illness, generally utilizing cognitive screening measures or case reports, suggests presence of deficits in attention and executive function. This observational study investigated cognitive functioning among individuals with persistent cognitive complaints about 5.

View Article and Find Full Text PDF

The field of Alzheimer's disease (AD) research critically lacks an all-inclusive etiology theory that would integrate existing hypotheses and explain the heterogeneity of disease trajectory and pathologies observed in each individual patient. Here, we propose a novel comprehensive theory that we named: the multipathology convergence to chronic neuronal stress. Our new theory reconsiders long-standing dogmas advanced by previous incomplete theories.

View Article and Find Full Text PDF

Background: Prior studies suggest comparable effectiveness of dimethyl fumarate (DMF) and fingolimod (FTY) in multiple sclerosis (MS) using relapse, Expanded Disability Status Score (EDSS), and magnetic resonance imaging (MRI) lesion metrics.

Objective: Compare the real-world effectiveness of DMF versus FTY using quantitative, validated neuroperformance tests, MRI, and serum neurofilament light chain (sNfL) outcomes while controlling for between-group differences.

Methods: Patients were eligible if on DMF or FTY when first enrolled in the MS Partners Advancing Technology and Health Solutions (MS PATHS) network and had ≥1-year follow-up in MS PATHS.

View Article and Find Full Text PDF

Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease.

Alzheimers Res Ther

January 2022

Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.

Background: Genome-wide association studies (GWAS) have identified numerous susceptibility loci for Alzheimer's disease (AD). However, utilizing GWAS and multi-omics data to identify high-confidence AD risk genes (ARGs) and druggable targets that can guide development of new therapeutics for patients suffering from AD has heretofore not been successful.

Methods: To address this critical problem in the field, we have developed a network-based artificial intelligence framework that is capable of integrating multi-omics data along with human protein-protein interactome networks to accurately infer accurate drug targets impacted by GWAS-identified variants to identify new therapeutics.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers are focusing on collecting repeated data in studies to track changes in measurements over time, which may help identify new drug targets related to disease progression.
  • To accurately determine the relationship between measurements, they recommend using partial correlation after adjusting for a third variable that influences one of the measurements.
  • The study suggests using linear regression models to calculate residuals and then applying these in a linear mixed model for better partial correlation estimates, supported by real-world examples and numerical comparisons.
View Article and Find Full Text PDF

Background: The impact of multiple sclerosis (MS) disease-modifying therapies (DMTs) on SARS-CoV-2 vaccination response is uncertain.

Methods: Post-SARS-CoV-2 vaccination blood samples across multiple DMTs were tested for SARS-CoV-2 immunoglobulin G (IgG) response.

Results: Three hundred twenty-two people with MS were included; 91.

View Article and Find Full Text PDF

Background: Fear of falling avoidance behavior (FFAB) is common in parkinsonisms and results in potentially mitigable downstream consequences.

Objective: Determine the characteristics of individuals with parkinsonisms most associated with FFAB.

Methods: A retrospective, cross-sectional study was conducted from medical records data of 142 patients with parkinsonisms.

View Article and Find Full Text PDF

Fractionating performance of a verbal list-learning test can provide a nuanced interpretation of the relationship between brain networks and learning and memory abilities. Within older adult samples, including those with mild cognitive impairment and Alzheimer’s disease, cortical volumes for attention and executive functioning networks correlate more strongly with neuropsychological performance measures of early learning trials relative to late learning and delayed recall. In contrast, medial temporal lobe (MTL) structures, such as the hippocampus, are more strongly correlated to performance on late learning and delayed recall measures relative to early learning.

View Article and Find Full Text PDF
Article Synopsis
  • There are unresolved questions about using cladribine tablets for multiple sclerosis treatment during the COVID-19 pandemic, particularly concerning vaccination.
  • An international group of MS experts developed consensus-based recommendations to clarify how cladribine treatment interacts with COVID-19 vaccination.
  • The final recommendations cover vaccination necessity, timing relative to treatment, and safety, achieving consensus agreement from a broad panel of experts.
View Article and Find Full Text PDF

Inequalities in mental healthcare and lack of social support during the COVID-19 pandemic have lowered quality of life and increased overall burden of disease in people with Parkinson's (PWP). Although the pandemic has brought attention to these inequalities, they are long standing and will persist unless addressed. Lack of awareness of mental health issues is a major barrier and even when recognized disparities based on race, gender, and socioeconomic factors limit access to already scarce resources.

View Article and Find Full Text PDF

The prevailing scientific literature aggregates Asians living in America into one omnibus category and thus can problematically result in a subpar and at times inaccurate understanding of health, social and cultural factors necessary for competent and informed medical care. A literature search was conducted by cultural experts familiar with Asian Indian culture with a focus on immigrants from this community living in the US. Database using search engines was sought in the following domains: immigration patterns, prevalence for key medical and neurological conditions commonly associated with cognitive dysfunction, psychiatric/psychological needs in the community, some preliminary neuropsychological testing considerations while working with this community, and treatment considerations that could affect adherence and efficacy of outcomes.

View Article and Find Full Text PDF

Introduction: We examined the association between Alzheimer's disease (AD) and type 2 diabetes mellitus (DM) and hypothesized that diabetes is associated with an increased pathological burden in clinically and pathologically diagnosed AD.

Methods: All data were obtained from the Uniform Data Set (UDS) v3, the Neuropathology Data Set, and the Researcher's Data Dictionary-Genetic Data from the National Alzheimer's Coordinating Center. The dataset (37 cases with diabetes and 1158 cases without) relies on autopsy-confirmed data in clinically diagnosed AD patients who were assessed for diabetes type in form A5 or D2 during at least one visit.

View Article and Find Full Text PDF
Article Synopsis
  • - Early deaf (ED) individuals excel in visual detection of space and motion compared to normal hearing (NH) individuals, but their multisensory temporal processing abilities remain uncertain.
  • - A study used a temporal order judgment (TOJ) task to compare visuotactile processing in ED and NH groups, revealing that both performed similarly despite different brain responses.
  • - Results showed that ED individuals had significantly larger brain responses in the posterior superior temporal sulcus (pSTS) and displayed stronger somatomotor and weaker visual connections, indicating a shift in sensory processing due to the lack of auditory input.
View Article and Find Full Text PDF

Videoconferencing Software Options for Telemedicine: A Review for Movement Disorder Neurologists.

Front Neurol

October 2021

Department of Neurology, Centre of Expertise for Parkinson & Movement Disorders, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, Netherlands.

The use of telemedicine has increased to address the ongoing healthcare needs of patients with movement disorders. We aimed to describe the technical and basic security features of the most popular telemedicine videoconferencing software. We conducted a systematic review of articles/websites about "Telemedicine," "Cybersecurity," and "Videoconferencing software.

View Article and Find Full Text PDF

Background: The initial COVID-19 pandemic shutdown led to the canceling of elective surgeries throughout most of the USA and Canada.

Objective: This survey was carried out on behalf of the Parkinson Study Group (PSG) to understand the impact of the shutdown on deep brain stimulation (DBS) practices in North America.

Methods: A survey was distributed through RedCap® to the members of the PSG Functional Neurosurgical Working Group.

View Article and Find Full Text PDF

Intimate partner violence (IPV) survivors frequently report face, head, and neck as their injury site. Many mild traumatic brain injuries (TBIs) are undiagnosed or underreported among IPV survivors while these injuries may be linked to changes in brain function or pathology. TBI sustained due to IPV often occurs over time and ranges in severity.

View Article and Find Full Text PDF

Multiple Sclerosis Progression Discussion Tool Usability and Usefulness in Clinical Practice: Cross-sectional, Web-Based Survey.

J Med Internet Res

October 2021

Centre for Neuromuscular and Neurological Disorders, Western Australian Neuroscience Research Institute, The University of Western Australia, Perth, Australia.

Background: A digital tool, Multiple Sclerosis Progression Discussion Tool (MSProDiscuss), was developed to facilitate discussions between health care professionals (HCPs) and patients in evaluating early, subtle signs of multiple sclerosis (MS) disease progression.

Objective: The aim of this study is to report the findings on the usability and usefulness of MSProDiscuss in a real-world clinical setting.

Methods: In this cross-sectional, web-based survey, HCPs across 34 countries completed an initial individual questionnaire (comprising 7 questions on comprehensibility, usability, and usefulness after using MSProDiscuss during each patient consultation) and a final questionnaire (comprising 13 questions on comprehensibility, usability, usefulness, and integration and adoption into clinical practice to capture the HCPs' overall experience of using the tool).

View Article and Find Full Text PDF

Dementia with Lewy bodies (DLB) research has seen a significant growth in international collaboration over the last three decades. However, researchers face a challenge in identifying large and diverse samples capable of powering longitudinal studies and clinical trials. The DLB research community has begun to focus efforts on supporting the development and harmonization of consortia, while also continuing to forge networks within which data and findings can be shared.

View Article and Find Full Text PDF

To collect evidence of validity for a selection of digital tests on the Philips IntelliSpace Cognition (ISC) platform. A total of 200 healthy participants (age 50-80) completed both the ISC battery and an analog version of the battery during separate visits. The battery included the following screeners and cognitive tests: Mini-Mental State Examination (2 edition), Clock Drawing Test, Trail-Making Test (TMT), Rey Auditory Verbal Learning Test (RAVLT), Rey-Osterrieth Complex Figure Test (ROCFT), Letter Fluency, Star Cancellation Test, and Digit Span Test.

View Article and Find Full Text PDF

Neurological disorders significantly impact the world's economy due to their often chronic and life-threatening nature afflicting individuals which, in turn, creates a global disease burden. The Group of Twenty (G20) member nations, which represent the largest economies globally, should come together to formulate a plan on how to overcome this burden. The Neuroscience-20 (N20) initiative of the Society for Brain Mapping and Therapeutics (SBMT) is at the vanguard of this global collaboration to comprehensively raise awareness about brain, spine, and mental disorders worldwide.

View Article and Find Full Text PDF

Consensus Curriculum for Fellowship Training in Multiple Sclerosis and Neuroimmunology.

Neurol Clin Pract

August 2021

Cleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.

Management of multiple sclerosis and neuroimmunologic disorders has become increasingly complex because of the expanding number of recognized neuroimmune disorders, increased number of therapeutic options, and multidisciplinary care management needs of people with multiple sclerosis and neuroimmunologic disorders. More subspecialists are needed to optimize care of these patients, and many fellowship programs have been created or expanded to increase the subspecialty workforce. Consequently, defining the scope and standardizing fellowship training is essential to ensure that trainees receive high-quality training.

View Article and Find Full Text PDF